DCBO vs CRM

For growth investors, Docebo Inc.

(DCBO) is the stronger pick with 20. 0% revenue growth year-over-year, versus 9. 6% for Salesforce, Inc. (CRM). Salesforce, Inc. (CRM) offers the better valuation at 23. 2x trailing P/E (15. 4x forward), making it the more compelling value choice. Analysts rate Docebo Inc. (DCBO) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Salesforce, Inc.

(CRM) is the cheapest at 23. 2x versus Docebo Inc. at 23. 2x. On forward P/E, Docebo Inc. is actually cheaper at 12. 3x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Salesforce, Inc.

(CRM) delivered a total return of -15. 2%, compared to -59. 1% for Docebo Inc. (DCBO). Over 10 years, the gap is even starker: CRM returned +149. 0% versus DCBO's -60. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Salesforce, Inc.

(CRM) is the lower-risk stock at 0. 82β versus Docebo Inc. 's 1. 13β — meaning DCBO is approximately 38% more volatile than CRM relative to the S&P 500. On balance sheet safety, Docebo Inc. (DCBO) carries a lower debt/equity ratio of 3% versus 11% for Salesforce, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Docebo Inc.

(DCBO) is pulling ahead at 20. 0% versus 9. 6% for Salesforce, Inc. (CRM). On earnings-per-share growth, the picture is similar: Docebo Inc. grew EPS 920. 2% year-over-year, compared to 22. 6% for Salesforce, Inc.. Over a 3-year CAGR, DCBO leads at 27. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Salesforce, Inc.

(CRM) is the more profitable company, earning 18. 0% net margin versus 12. 3% for Docebo Inc. — meaning it keeps 18. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRM leads at 21. 5% versus 9. 8% for DCBO. At the gross margin level — before operating expenses — DCBO leads at 81. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Docebo Inc.

(DCBO) trades at 12. 3x forward P/E versus 15. 4x for Salesforce, Inc. — 3. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRM: 58. 4% to $287. 00.

In this comparison, CRM (0.

9% yield) pays a dividend. DCBO does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Salesforce, Inc.

(CRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 82), 0. 9% yield, +149. 0% 10Y return). Both have compounded well over 10 years (CRM: +149. 0%, DCBO: -60. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DCBO is a small-cap high-growth stock; CRM is a mid-cap quality compounder stock. CRM pays a dividend while DCBO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.